Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Pulmonary Embolism and Thrombosis: early-phase trial registry

2 of 2 indexed Pulmonary Embolism and Thrombosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Pulmonary Embolism and Thrombosis: 2 US clinical trials tracked, 2 recruiting.

Pulmonary Embolism and Thrombosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Rushad Patell, running 1 of these trials.

Enrollment posture brief

Registry condition pulmonary-embolism-and-thrombosis

OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Pulmonary Embolism and T (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Pulmonary Embolism and Thrombosis

Pulmonary Embolism and Thrombosis lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pulmonary Embolism and Thrombosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pulmonary Embolism and Thrombosis is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Pulmonary Embolism and Thrombosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

No EHR (electronic health record) alert Other
1 trials
EHR (electronic health record) alert Other
1 trials
Apixaban Drug
1 trials

US sites by state

Facility locations filed on Pulmonary Embolism and Thrombosis trials. A trial with sites in several states counts in each.

Utah 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pulmonary Embolism and Thrombosis page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Pulmonary Embolism and Thrombosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Rushad Patell sponsors the most Pulmonary Embolism and Thrombosis trials on record, review their full trial history before evaluating a specific study. See Rushad Patell's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Embolism and Thrombosis condition card totals 2 registered trials; most-linked intervention No EHR (electronic health record) alert; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.